En­do sues FDA over its han­dling of gener­ic Adren­a­lin ap­provals

En­do Phar­ma­ceu­ti­cals is su­ing the FDA over its ap­proval of a gener­ic ver­sion of En­do’s Adren­a­lin in­jec­tions to treat al­ler­gic re­ac­tions, re­quest­ing an emer­gency stay …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER